Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.

about

Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.

Item

http://www.wikidata.org/entity/Q40211318

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of different sofosbuvir ...... patitis C genotype 4 patients.

@en

type

Item

label

Impact of different sofosbuvir ...... patitis C genotype 4 patients.

@en

prefLabel

Impact of different sofosbuvir ...... patitis C genotype 4 patients.

@en

P1476

Impact of different sofosbuvir ...... epatitis C genotype 4 patients

@en

P2093

Aisha Elsharkawy

http://www.w3.org/2001/XMLSchema#string

Gamal Esmat

http://www.w3.org/2001/XMLSchema#string

Mohamed Negm

http://www.w3.org/2001/XMLSchema#string

Mohammad Mohey

http://www.w3.org/2001/XMLSchema#string

Rabab Fouad

http://www.w3.org/2001/XMLSchema#string

Rasha Eletreby

http://www.w3.org/2001/XMLSchema#string

P2860

Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

Global epidemiology and genotype distribution of the hepatitis C virus infection

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies.

Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis.

The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life.

P304

773-778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17474124.2017.1326816

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M AbdAllah

Zeinab Soliman

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480808

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir